|
| Ipsilateral Lung Cancer | Contralateral Lung Cancer | ||
| Lung cancer stage | Stage I | 37 (33%) | Stage I | 34 (32%) |
| Stage II | 12 (11%) | Stage II | 16 (15%) | |
| Stage III | 25 (23%) | Stage III | 16 (15%) | |
| Stage IV | 37 (33%) | Stage IV | 40 (38%) | |
| Lung cancer tumor subtypes (%) | Adenocarcinoma | 47 (42%) | Adenocarcinoma | 38 (36%) |
| NSCLC NOSc | 28 (25%) | NSCLC NOS | 27 (25%) | |
| Squamous cell carcinoma | 18 (16%) | Small cell carcinoma | 17 (16%) | |
| Small cell carcinoma | 14 (13%) | Squamous cell carcinoma | 16 (15%) | |
| Large cell carcinoma | 2 (2%) | Large cell l carcinoma | 7 (7%) | |
| Carcinoid | 2 (2%) | Carcinoid | 1 (1%) | |